To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is
more effective than narrowband ultraviolet B alone in the treatment of vitiligo.
Other: Phototherapy and Photochemotherapy
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01732965
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
All locations for NCT01732965
United States (1)
Henry Ford Dermatology
Detroit, Michigan, United States, 48202
View full eligibility
Tris trial is registered with FDA with number: NCT01732965. The sponsor of the trial is Henry Ford Health System and it is looking for 10 volunteers for the current phase.
Official trial title: Prospective Open Parallel Right to Left Bilateral Study Comparing Narrowband Ultraviolet B Alone Versus Narrowband Ultraviolet B and Psoralen Plus Ultraviolet A for the Treatment of Vitiligo
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!